These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2273999)

  • 21. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
    Bassett ML; Mullen KD; Skolnick P; Jones EA
    Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study.
    Gyr K; Meier R; Häussler J; Boulétreau P; Fleig WE; Gatta A; Holstege A; Pomier-Layrargues G; Schalm SW; Groeneweg M; Scollo-Lavizzari G; Ventura E; Zeneroli ML; Williams R; Yoo Y; Amrein R
    Gut; 1996 Aug; 39(2):319-24. PubMed ID: 8977350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current possibilities in the therapy of hepatic encephalopathy].
    Meier PJ; Bansky G
    Schweiz Med Wochenschr; 1990 Apr; 120(15):553-6. PubMed ID: 2159659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic hepatic encephalopathy treated by long-term intravenous administration of flumazenil in ambulatory care].
    Péroux JL; Paolini O; Tran A; Frappa B; Rampal P
    Gastroenterol Clin Biol; 1996 Feb; 20(1):106-8. PubMed ID: 8734316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil.
    Ferenci P; Grimm G; Meryn S; Gangl A
    Gastroenterology; 1989 Jan; 96(1):240-3. PubMed ID: 2491822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.
    Meier R; Gyr K
    Eur J Anaesthesiol Suppl; 1988; 2():139-46. PubMed ID: 2842130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzodiazepine antagonist in the treatment of human hepatic encephalopathy.
    Ferenci P; Grimm G
    Adv Exp Med Biol; 1990; 272():255-65. PubMed ID: 2103692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study.
    Laccetti M; Manes G; Uomo G; Lioniello M; Rabitti PG; Balzano A
    Dig Liver Dis; 2000 May; 32(4):335-8. PubMed ID: 11515632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study.
    Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G
    Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persisting benzodiazepine metabolites responsible for the reaction to the benzodiazepine antagonist flumazenil in patients with hepatic encephalopathy.
    Meier R; Gyr K; Scholer A
    Gastroenterology; 1991 Jul; 101(1):274-5. PubMed ID: 2044919
    [No Abstract]   [Full Text] [Related]  

  • 33. Flumazenil-induced improvement of the central dopaminergic system in rats with acute hepatic failure.
    Yano M; Adachi N; Liu K; Arai T
    J Neurosurg Anesthesiol; 2005 Apr; 17(2):69-74. PubMed ID: 15840991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flumazenil: a benzodiazepine antagonist.
    Hoffman EJ; Warren EW
    Clin Pharm; 1993 Sep; 12(9):641-56; quiz 699-701. PubMed ID: 8306565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudocervical cord syndrome: a deceptive flumazenil reversible manifestation of hepatic encephalopathy.
    McDonald JW; Bautista RE; Gutmann DH
    Arch Neurol; 1996 Oct; 53(10):956. PubMed ID: 8859053
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acute effect of flumazenil in refractory hepatic encephalopathy].
    Chesta J; Brahm J; Poniachik J
    Rev Med Chil; 1989 Sep; 117(9):1049-50. PubMed ID: 2519472
    [No Abstract]   [Full Text] [Related]  

  • 37. Flumazenil and hepatic encephalopathy.
    Amaral OB; Quevedo J; Walz R; Kapczinski F
    Hepatology; 1999 Apr; 29(4):1338-9. PubMed ID: 10336339
    [No Abstract]   [Full Text] [Related]  

  • 38. Is flumazenil an alternative for the treatment of hepatic encephalopathy?
    Reyes D; Barrera F
    Medwave; 2017 Dec; 17(9):e7113. PubMed ID: 29286356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flumazenil and hepatic encephalopathy.
    Klotz U; Walker S
    Lancet; 1989 Jan; 1(8630):155-6. PubMed ID: 2563065
    [No Abstract]   [Full Text] [Related]  

  • 40. Flumazenil: potential implications for hepatic encephalopathy.
    Jones EA; Basile AS; Mullen KD; Gammal SH
    Pharmacol Ther; 1990; 45(3):331-43. PubMed ID: 2105510
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.